Featured Editorial
A Standard Approach To Classify Visible Particles In Parenteral Products
By Scott Ewan, BioPhorum Operations Group

The presence of visible particles in parenteral biopharmaceuticals remains a hot topic in the industry. Despite regulatory bodies targeting a goal of no visible particles, and despite industry’s focus on further improving the efficacy of inspection processes, particles will continue to be found during production and in the marketplace.

Industry Insights
Optimizing Your Plate-Based Assay Workflows
Webinar | Dassault Systèmes BIOVIA

Using workflow based software solutions to guide scientists through various processes in low to high throughput screening campaigns.

Most Popular News
Whatman GD/X Syringe Filters
GE Healthcare Life Sciences